These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 15658072)
21. Pharmacokinetics of butorphanol in cats after intramuscular and buccal transmucosal administration. Wells SM; Glerum LE; Papich MG Am J Vet Res; 2008 Dec; 69(12):1548-54. PubMed ID: 19045999 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers. Coda BA; Rudy AC; Archer SM; Wermeling DP Anesth Analg; 2003 Jul; 97(1):117-23, table of contents. PubMed ID: 12818953 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of butorphanol in horses after intramuscular injection. Sellon DC; Papich MG; Palmer L; Remund B J Vet Pharmacol Ther; 2009 Feb; 32(1):62-5. PubMed ID: 19161457 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and pharmacodynamics comparison between subcutaneous and intravenous butorphanol administration in horses. Chiavaccini L; Claude AK; Lee JH; Ross MK; Meyer RE; Langston VC J Vet Pharmacol Ther; 2015 Aug; 38(4):365-74. PubMed ID: 25484250 [TBL] [Abstract][Full Text] [Related]
25. A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: importance of the timing of butorphanol administration. Vachharajani NN; Shyu WC; Nichola PS; Boulton DW Cephalalgia; 2002 May; 22(4):282-7. PubMed ID: 12100090 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery. Foster D; Upton R; Christrup L; Popper L Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and adverse effects of butorphanol administered by single intravenous injection or continuous intravenous infusion in horses. Sellon DC; Monroe VL; Roberts MC; Papich MG Am J Vet Res; 2001 Feb; 62(2):183-9. PubMed ID: 11212025 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Cass LM; Efthymiopoulos C; Bye A Clin Pharmacokinet; 1999; 36 Suppl 1():1-11. PubMed ID: 10429835 [TBL] [Abstract][Full Text] [Related]
29. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses. Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers. McAleer SD; Majid O; Venables E; Polack T; Sheikh MS J Clin Pharmacol; 2007 Jan; 47(1):13-8. PubMed ID: 17192497 [TBL] [Abstract][Full Text] [Related]
31. A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers. Agarwal SK; Kriel RL; Brundage RC; Ivaturi VD; Cloyd JC Epilepsy Res; 2013 Aug; 105(3):362-7. PubMed ID: 23561287 [TBL] [Abstract][Full Text] [Related]
32. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers. He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of butorphanol in broiler chickens. Singh PM; Johnson C; Gartrell B; Mitchinson S; Chambers P Vet Rec; 2011 Jun; 168(22):588. PubMed ID: 21628341 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of butorphanol tartrate in a long-acting poloxamer 407 gel formulation administered to Hispaniolan Amazon parrots (Amazona ventralis). Laniesse D; Guzman DS; Knych HK; Smith DA; Mosley C; Paul-Murphy JR; Beaufrère H Am J Vet Res; 2017 Jun; 78(6):688-694. PubMed ID: 28541145 [TBL] [Abstract][Full Text] [Related]
36. A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation. Wermeling DP; Record KA; Archer SM; Rudy AC Epilepsy Res; 2009 Feb; 83(2-3):124-32. PubMed ID: 19046855 [TBL] [Abstract][Full Text] [Related]
37. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers. Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic profile of beclomethasone dipropionate hydrofluoroalkane after intranasal administration versus oral inhalation in healthy subjects: results of a single-dose, randomized, open-label, 3-period crossover study. Ratner PH; Melchior A; Dunbar SA; Tantry SK; Dorinsky PM Clin Ther; 2012 Jun; 34(6):1422-31. PubMed ID: 22621776 [TBL] [Abstract][Full Text] [Related]
39. The bioavailability of intranasal and smoked methamphetamine. Harris DS; Boxenbaum H; Everhart ET; Sequeira G; Mendelson JE; Jones RT Clin Pharmacol Ther; 2003 Nov; 74(5):475-86. PubMed ID: 14586388 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers. Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]